NL-OMON23851已完成不适用
Studying the metabolism of sorafenib (Nexavar®) by OATP1Bblockage in adult cancer patients.
Erasmus Medical Center; Department of Medical Oncology0 个研究点目标入组 9 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age ≥18 years;
- •Histological/ cytological confirmed diagnosis of cancer treated with sorafenib monotherapy
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •Pregnant or child nursing patients;
研究者
相似试验
进行中（未招募）
不适用
Studying the influence of rifampicin administration on the processing of sorafenib in adult patients with cancerCancerEUCTR2013-001525-10-NLErasmus MC
已完成
不适用
Studying the metabolism of sorafenib (Nexavar®) by OATP1B blockage in adult cancer patientsNL-OMON38631Erasmus MC, Universitair Medisch Centrum Rotterdam9
已完成
不适用
Sorafenib pharmacokinetics in non small cell lung cancer patients: an in;vivo study using positron emission tomographylung cancer10038666NL-OMON37648Vrije Universiteit Medisch Centrum12
已完成
1 期
Drug Interaction Study of Sorafenib and Rapamycin in Advanced MalignanciesAdvanced Solid TumorNCT00449280University of Chicago34
已完成
1 期
Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal CancerMetastatic Colorectal CancerNCT00780169Ottawa Hospital Research Institute16